Context-dependent autophagy in cancer: deciphering cytoprotective vs. cytotoxic roles and therapeutic modulation strategies

Samer Osama Kostandy, Salwa Aburageh Abuiessa, Mai Mostafa Helmy, Maged Wasfy Helmy

Abstract


Autophagy is a highly conserved cellular process activated when cells are exposed to stress. It is responsible for maintaining cellular homeostasis by degrading and recycling the exhausted cell components. However, autophagy is considered a cell survival mechanism; recent studies revealed its dual role in cancer. Autophagy can act as cytoprotective in early tumor stages or cytotoxic in advanced malignancies. This review explores the underlying molecular mechanisms and key regulatory pathways of autophagy, such as mTOR, AMPK, and p53, and their roles in tumorigenesis. The contradictory nature of autophagy in cancer varies according to the cellular context and depends on genomic stability, metabolic adaptation, immune evasion, and therapy resistance. Additionally, this review discusses different therapeutic strategies targeting autophagy, including inhibitors such as hydroxychloroquine and inducers like rapamycin, which have shown promise in modulating autophagy for improved cancer treatment outcomes. The review also examines the role of autophagy in cancer stem cells, metastasis, and therapy resistance, providing insights into how autophagy modulation can enhance chemotherapy, radiotherapy, and immunotherapy. Given its context-dependent functions, a deeper understanding of autophagy’s intricate regulation is crucial for developing precision medicine approaches to effectively integrate autophagy-targeting strategies in cancer treatment.

Received on, 05 March 2025

Accepted on, 18 March 2025

Published on, 15 April 2025


Keywords


autophagy, cytoprotective, cytotoxic, cellular context, cancer

Full Text:

PDF

References


Gómez-Virgilio L, Silva-Lucero MDC, Flores-Morelos DS, Gallardo-Nieto J, Lopez-Toledo G, Abarca-Fernandez AM, et al. Autophagy: A Key Regulator of Homeostasis and Disease: An Overview of Molecular Mechanisms and Modulators. Vol. 11, Cells. 2022.

Khandia R, Dadar M, Munjal A, Dhama K, Karthik K, Tiwari R, et al. A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: Current knowledge and prospects for disease prevention, novel drug design, and therapy. Vol. 8, Cells. 2019.

Parzych KR, Klionsky DJ. An overview of autophagy: Morphology, mechanism, and regulation. Vol. 20, Antioxidants and Redox Signaling. 2014.

Harnett MM, Pineda MA, Latré de Laté P, Eason RJ, Besteiro S, Harnett W, et al. From Christian de Duve to Yoshinori Ohsumi: More to autophagy than just dining at home. Vol. 40, Biomedical Journal. 2017.

Ariosa AR, Lahiri V, Lei Y, Yang Y, Yin Z, Zhang Z, et al. A perspective on the role of autophagy in cancer. Biochim Biophys Acta Mol Basis Dis. 2021;1867(12).

Vitto VAM, Bianchin S, Zolondick AA, Pellielo G, Rimessi A, Chianese D, et al. Molecular Mechanisms of Autophagy in Cancer Development, Progression, and Therapy. Vol. 10, Biomedicines. 2022.

Yang ZJ, Chee CE, Huang S, Sinicrope FA. The role of autophagy in cancer: Therapeutic implications. Vol. 10, Molecular Cancer Therapeutics. 2011.

Rakesh R, PriyaDharshini LC, Sakthivel KM, Rasmi RR. Role and regulation of autophagy in cancer. Biochim Biophys Acta Mol Basis Dis. 2022;1868(7).

Cook KL, Wärri A, Soto-Pantoja DR, Clarke PAG, Cruz MI, Zwart A, et al. Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer. Clinical Cancer Research. 2014;20(12).

Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 2006;10(1).

Kaushik S, Massey AC, Mizushima N, Cuervo AM. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol Biol Cell. 2008;19(5).

Li WW, Li J, Bao JK. Microautophagy: Lesser-known self-eating. Vol. 69, Cellular and Molecular Life Sciences. 2012.

Alfaro IE, Albornoz A, Molina A, Moreno J, Cordero K, Criollo A, et al. Chaperone mediated autophagy in the crosstalk of neurodegenerative diseases and metabolic disorders. Vol. 10, Frontiers in Endocrinology. 2019.

Wang CW, Klionsky DJ. The Molecular Mechanism of Autophagy. Molecular Medicine. 2003 Mar 15;9(3–4):65–76.

Zachari M, Ganley IG. The mammalian ULK1 complex and autophagy initiation. Vol. 61, Essays in Biochemistry. 2017.

Thoresen SB, Pedersen NM, Liestøl K, Stenmark H. A phosphatidylinositol 3-kinase class III sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates cytokinesis and degradative endocytic traffic. Exp Cell Res. 2010;316(20).

Iriondo MN, Etxaniz A, Varela YR, Ballesteros U, Lázaro M, Valle M, et al. Effect of ATG12–ATG5-ATG16L1 autophagy E3-like complex on the ability of LC3/GABARAP proteins to induce vesicle tethering and fusion. Cellular and Molecular Life Sciences. 2023;80(2).

Gatica D, Lahiri V, Klionsky DJ. Cargo recognition and degradation by selective autophagy. Vol. 20, Nature Cell Biology. 2018.

Hennig P, Fenini G, Filippo M Di, Karakaya T, Beer HD. The pathways underlying the multiple roles of p62 in inflammation and cancer. Vol. 9, Biomedicines. 2021.

Nishimura T, Tooze SA. Emerging roles of ATG proteins and membrane lipids in autophagosome formation. Vol. 6, Cell Discovery. 2020.

Roy SG. Regulation of autophagy by miRNAs in human diseases. Vol. 64, Nucleus (India). 2021.

Orioli E, De Marchi E, Giuliani AL, Adinolfi E. P2X7 Receptor Orchestrates Multiple Signalling Pathways Triggering Inflammation, Autophagy and Metabolic/Trophic Responses. Curr Med Chem. 2017;24(21).

Levine B, Sinha S, Kroemer G. Bcl-2 family members: Dual regulators of apoptosis and autophagy. Vol. 4, Autophagy. 2008.

Afinanisa Q, Cho MK, Seong HA. AMPK localization: A key to differential energy regulation. Vol. 22, International Journal of Molecular Sciences. 2021.

Sabapathy K. Role of the JNK Pathway in human diseases. In: Progress in Molecular Biology and Translational Science. 2012.

Chun Y, Kim J. Autophagy: An essential degradation program for cellular homeostasis and life. Vol. 7, Cells. 2018.

Ma K, Chen G, Li W, Kepp O, Zhu Y, Chen Q. Mitophagy, Mitochondrial Homeostasis, and Cell Fate. Vol. 8, Frontiers in Cell and Developmental Biology. 2020.

Guan X, Iyaswamy A, Sreenivasmurthy SG, Su C, Zhu Z, Liu J, et al. Mechanistic Insights into Selective Autophagy Subtypes in Alzheimer’s Disease. Vol. 23, International Journal of Molecular Sciences. 2022.

Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: The clash between damage and metabolic needs. Vol. 22, Cell Death and Differentiation. 2015.

Bialik S, Dasari SK, Kimchi A. Autophagy-dependent cell death - where, how and why a cell eats itself to death. Vol. 131, Journal of Cell Science. 2018.

Wilson EN, Bristol ML, Di X, Maltese WA, Koterba K, Beckman MJ, et al. A Switch Between Cytoprotective and Cytotoxic Autophagy in the Radiosensitization of Breast Tumor Cells by Chloroquine and Vitamin D. Horm Cancer. 2011;2(5).

Miller DR, Thorburn A. Autophagy and organelle homeostasis in cancer. Vol. 56, Developmental Cell. 2021.

Huang T, Song X, Yang Y, Wan X, Alvarez AA, Sastry N, et al. Autophagy and hallmarks of cancer. Crit Rev Oncog. 2018;23(5–6).

Schmitt CA, Wang B, Demaria M. Senescence and cancer — role and therapeutic opportunities. Vol. 19, Nature Reviews Clinical Oncology. 2022.

Gerada C, Ryan KM. Autophagy, the innate immune response and cancer. Vol. 14, Molecular Oncology. 2020.

Zaarour RF, Azakir B, Hajam EY, Nawafleh H, Zeinelabdin NA, Engelsen AST, et al. Role of hypoxia-mediated autophagy in tumor cell death and survival. Vol. 13, Cancers. 2021.

Zhang J, Xiang Q, Wu M, Lao YZ, Xian YF, Xu HX, et al. Autophagy Regulators in Cancer. Vol. 24, International Journal of Molecular Sciences. 2023.

Pan H, Chen L, Xu Y, Han W, Lou F, Fei W, et al. Autophagy-associated immune responses and cancer immunotherapy. Oncotarget. 2016;7(16).

Hwang YK, Lee DH, Lee EC, Oh JS. Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance. Cells. 2024 Aug 11;13(16):1332.

Jain K, Paranandi KS, Sridharan S, Basu A. Autophagy in breast cancer and its implications for therapy. Vol. 3, American Journal of Cancer Research. 2013.

Manic G, Obrist F, Kroemer G, Vitale I, Galluzzi L. Chloroquine and hydroxychloroquine for cancer therapy. Vol. 1, Molecular and Cellular Oncology. 2014.

Alers S, Löffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks. Mol Cell Biol. 2012;32(1).

Skolariki A, D’Costa J, Little M, Lord S. Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic. Vol. 3, Exploration of Targeted Anti-tumor Therapy. 2022.

Butler DE, Marlein C, Walker HF, Frame FM, Mann VM, Simms MS, et al. Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer. Oncotarget. 2017;8(34).

Sanaei MJ, Razi S, Pourbagheri-Sigaroodi A, Bashash D. The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles. Vol. 18, Translational Oncology. 2022.

Tian T, Li X, Zhang J. mTOR signaling in cancer and mtor inhibitors in solid tumor targeting therapy. Vol. 20, International Journal of Molecular Sciences. 2019.

Liu T, Zhang J, Li K, Deng L, Wang H. Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy. Vol. 11, Frontiers in Pharmacology. 2020.

Tasdemir E, Maiuri MC, Morselli E, Criollo A, D’Amelio M, Djavaheri-Mergny M, et al. A dual role of p53 in the control of autophagy. Autophagy. 2008;4(6).

Shi Y, Norberg E, Vakifahmetoglu-Norberg H. Mutant p53 as a Regulator and Target of Autophagy. Vol. 10, Frontiers in Oncology. 2021.

Menichini P, Monti P, Speciale A, Cutrona G, Matis S, Fais F, et al. Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair? Cells. 2021 Jan 7;10(1):98.

Pandey A, Yadav P, Shukla S. Unfolding the role of autophagy in the cancer metabolism. Biochem Biophys Rep. 2021;28.

Zhao T, Ren H, Jia L, Chen J, Xin W, Yan F, et al. Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma. Oncotarget. 2015 Feb 10;6(4):2250–62.

Maan M, Peters JM, Dutta M, Patterson AD. Lipid metabolism and lipophagy in cancer. Biochem Biophys Res Commun. 2018;504(3).

Villar VH, Merhi F, Djavaheri-Mergny M, Durán R V. Glutaminolysis and autophagy in cancer. Vol. 11, Autophagy. 2015.

Chang H, Zou Z. Targeting autophagy to overcome drug resistance: further developments. Vol. 13, Journal of Hematology and Oncology. 2020.

Li D, Peng X, He G, Liu J, Li X, Lin W, et al. Crosstalk between autophagy and CSCs: molecular mechanisms and translational implications. Vol. 14, Cell Death and Disease. 2023.

Jahangiri L, Ishola T, Pucci P, Trigg RM, Pereira J, Williams JA, et al. The role of autophagy and lncrnas in the maintenance of cancer stem cells. Vol. 13, Cancers. 2021.

Nazio F, Bordi M, Cianfanelli V, Locatelli F, Cecconi F. Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications. Vol. 26, Cell Death and Differentiation. 2019.

Strippoli R, Niayesh-Mehr R, Adelipour M, Khosravi A, Cordani M, Zarrabi A, et al. Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression. Vol. 16, Cancers. 2024.

Gundamaraju R, Lu W, Paul MK, Jha NK, Gupta PK, Ojha S, et al. Autophagy and EMT in cancer and metastasis: Who controls whom? Biochim Biophys Acta Mol Basis Dis. 2022;1868(9).

Leone K, Poggiana C, Zamarchi R. The interplay between circulating tumor cells and the immune system: From immune escape to cancer immunotherapy. Vol. 8, Diagnostics. 2018.

Agalakova NI. Chloroquine and Chemotherapeutic Compounds in Experimental Cancer Treatment. Vol. 25, International Journal of Molecular Sciences. 2024.

Schiliro C, Firestein BL. Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Vol. 10, Cells. 2021.

Rascio F, Spadaccino F, Rocchetti MT, Castellano G, Stallone G, Netti GS, et al. The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review. Vol. 13, Cancers. 2021.

Rahman MA, Park MN, Rahman MH, Rashid MM, Islam R, Uddin MJ, et al. p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets. Vol. 10, Frontiers in Cell and Developmental Biology. 2022.

Rosenfeldt MT, O’Prey J, Morton JP, Nixon C, Mackay G, Mrowinska A, et al. P53 status determines the role of autophagy in pancreatic tumour development. Nature. 2013;504(7479).

McKnight NC, Yue Z. Beclin 1, an Essential Component and Master Regulator of PI3K-III in Health and Disease. Curr Pathobiol Rep. 2013;1(4).

Hu YJ, Zhong JT, Gong L, Zhang SC, Zhou SH. Autophagy-related beclin 1 and head and neck cancers. Vol. 13, OncoTargets and Therapy. 2020.

Pattingre S, Tassa A, Qu X, Garuti R, Xiao HL, Mizushima N, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122(6).

Zamani M, Sadeghi E, Mokarram P, Kadkhodaei B, Ghasemi H. Autophagy related proteins as potential biomarkers in predicting cancer prognosis after chemoradiotherapy: systematic review and meta-analysis. Int J Radiat Biol. 2025 Mar 4;101(3):232–9.

Tanida I, Ueno T, Kominami E. LC3 and Autophagy. In 2008. p. 77–88.

Kumar A V., Mills J, Lapierre LR. Selective Autophagy Receptor p62/SQSTM1, a Pivotal Player in Stress and Aging. Vol. 10, Frontiers in Cell and Developmental Biology. 2022.

Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Vol. 18, Cell Death and Differentiation. 2011.

Bortnik S, Gorski SM. Clinical applications of autophagy proteins in cancer: From potential targets to biomarkers. Vol. 18, International Journal of Molecular Sciences. 2017.

Jiang P, Mizushima N. LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells. Methods. 2015;75.

Rajendran P, Renu K, Ali EM, Genena MAM, Veeraraghavan V, Sekar R, et al. Promising and challenging phytochemicals targeting LC3 mediated autophagy signaling in cancer therapy. Immun Inflamm Dis. 2024 Oct 22;12(10).

Park JM, Huang S, Wu TT, Foster NR, Sinicrope FA. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther. 2013;14(2).

Li W, Saud SM, Young MR, Chen G, Hua B. Targeting AMPK for cancer prevention and treatment. Vol. 6, Oncotarget. 2015.

Wyrsch P, Blenn C, Bader J, Althaus FR. Cell Death and Autophagy under Oxidative Stress: Roles of Poly(ADP-Ribose) Polymerases and Ca 2+ . Mol Cell Biol. 2012;32(17).

Velasco G, Verfaillie T, Salazar M, Agostinis P. Linking ER stress to autophagy: Potential implications for cancer therapy. International Journal of Cell Biology. 2010.

Xia H, Green DR, Zou W. Autophagy in tumour immunity and therapy. Vol. 21, Nature Reviews Cancer. 2021.

Anderson NM, Simon MC. The tumor microenvironment. Vol. 30, Current Biology. 2020.

Toledo B, Zhu Chen L, Paniagua-Sancho M, Marchal JA, Perán M, Giovannetti E. Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy. J Hematol Oncol. 2024 Jun 11;17(1):44.

Keerthana CK, Rayginia TP, Shifana SC, Anto NP, Kalimuthu K, Isakov N, et al. The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment. Vol. 14, Frontiers in Immunology. 2023.

Hill RM, Fok M, Grundy G, Parsons JL, Rocha S. The role of autophagy in hypoxia-induced radioresistance. Vol. 189, Radiotherapy and Oncology. 2023.

Taucher E, Mykoliuk I, Fediuk M, Smolle-Juettner FM. Autophagy, Oxidative Stress and Cancer Development. Vol. 14, Cancers. 2022.

Xu J, Patel NH, Gewirtz DA. Triangular relationship between p53, autophagy, and chemotherapy resistance. Int J Mol Sci. 2020;21(23).

Ahmadi-Dehlaghi F, Mohammadi P, Valipour E, Pournaghi P, Kiani S, Mansouri K. Autophagy: A challengeable paradox in cancer treatment. Vol. 12, Cancer Medicine. 2023.

Hasan A, Rizvi SF, Parveen S, Pathak N, Nazir A, Mir SS. Crosstalk Between ROS and Autophagy in Tumorigenesis: Understanding the Multifaceted Paradox. Vol. 12, Frontiers in Oncology. 2022.

Roy A, Bera S, Saso L, Dwarakanath BS. Role of autophagy in tumor response to radiation: Implications for improving radiotherapy. Vol. 12, Frontiers in Oncology. 2022.

Vara-Perez M, Felipe-Abrio B, Agostinis P. Mitophagy in cancer: A tale of adaptation. Vol. 8, Cells. 2019.

Tian Y, Song W, Li D, Cai L, Zhao Y. Resveratrol as a natural regulator of autophagy for prevention and treatment of cancer. Vol. 12, OncoTargets and Therapy. 2019.

Saleh T, As Sobeai HM, Alhoshani A, Alhazzani K, Almutairi MM, Alotaibi M. Effect of Autophagy Inhibitors on Radiosensitivity in DNA Repair-Proficient and -Deficient Glioma Cells. Medicina (Lithuania). 2022;58(7).

Shan C, Wang Y, Wang Y. The Crosstalk between Autophagy and Nrf2 Signaling in Cancer: from Biology to Clinical Applications. Int J Biol Sci. 2024 Nov 11;20(15):6181–206.

Fang S, Wan X, Zou X, Sun S, Hao X, Liang C, et al. Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway. Cell Death Dis. 2021;12(1).

Mai S, Muster B, Bereiter-Hahn J, Jendrach M. Autophagy proteins LC3B, ATG5 and ATG12 participate in quality control after mitochondrial damage and influence lifespan. Autophagy. 2012 Jan 27;8(1):47–62.

Cook KL, Shajahan AN, Clarke R. Autophagy and endocrine resistance in breast cancer. Vol. 11, Expert Review of Anticancer Therapy. 2011.

Silva VR, Neves SP, Santos L de S, Dias RB, Bezerra DP. Challenges and therapeutic opportunities of autophagy in cancer therapy. Vol. 12, Cancers. 2020.

Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Vol. 36, International Journal of Biochemistry and Cell Biology. 2004.

Cao Z, Tian K, Ran Y, Zhou H, Zhou L, Ding Y, et al. Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment. Front Immunol. 2024 Nov 22;15.

Wechman SL, Pradhan AK, DeSalle R, Das SK, Emdad L, Sarkar D, et al. New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity. In: Advances in Cancer Research. 2018.

Cheng XT, Xie YX, Zhou B, Huang N, Farfel-Becker T, Sheng ZH. Revisiting LAMP1 as a marker for degradative autophagy-lysosomal organelles in the nervous system. Vol. 14, Autophagy. 2018.

Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema KJ, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8).

Sahani MH, Itakura E, Mizushima N. Expression of the autophagy substrate SQSTM1/p62 is restored during prolonged starvation depending on transcriptional upregulation and autophagy-derived amino acids. Autophagy. 2014;10(3).

Wang L, Bi RR, Li L, Zhou K, Liu HL. Functional characteristics of autophagy in pancreatic cancer induced by glutamate metabolism in pancreatic stellate cells. Journal of International Medical Research. 2019;48(4).

Ngo V, Duennwald ML. Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease. Vol. 11, Antioxidants. 2022.

Li B, Wang W, Li Z, Chen Z, Zhi X, Xu J, et al. MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression. Cancer Lett. 2017;410.

Wei J, Wang X, Yu D, Tu Y, Yu Y. MicroRNA-mediated autophagy and drug resistance in cancer: mechanisms and therapeutic strategies. Discover Oncology. 2024 Nov 16;15(1):662.

Levine B, Kroemer G. Biological Functions of Autophagy Genes: A Disease Perspective. Vol. 176, Cell. 2019.

Tavakol S, Ashrafizadeh M, Deng S, Azarian M, Abdoli A, Motavaf M, et al. Autophagy modulators: Mechanistic aspects and drug delivery systems. Vol. 9, Biomolecules. 2019.

Li Y, Cao F, Li M, Li P, Yu Y, Xiang L, et al. Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages. Journal of Experimental and Clinical Cancer Research. 2018;37(1).

Boone BA, Bahary N, Zureikat AH, Moser AJ, Normolle DP, Wu WC, et al. Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma. Ann Surg Oncol. 2015;22(13).

Elshazly AM, Gewirtz DA. Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy? Vol. 12, Cells. 2023.

Lo Iacono M, Gaggianesi M, Bianca P, Brancato OR, Muratore G, Modica C, et al. Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy. Vol. 11, Journal of Clinical Medicine. 2022.

Verbaanderd C, Maes H, Schaaf MB, Sukhatme VP, Pantziarka P, Sukhatme V, et al. Repurposing drugs in oncology (ReDO) - Chloroquine and hydroxychloroquine as anti-cancer agents. Ecancermedicalscience. 2017;11.

Amaravadi RK, Winkler JD. Lys05: A new lysosomal autophagy inhibitor. Vol. 8, Autophagy. 2012.

Pal SK, Quinn DI. Differentiating mTOR inhibitors in renal cell carcinoma. Vol. 39, Cancer Treatment Reviews. 2013.

Dai ZJ, Gao J, Kang HF, Ma YG, Ma X Bin, Lu WF, et al. Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells. Drug Des Devel Ther. 2013;7.

Massihnia D, Galvano A, Fanale D, Perez A, Castiglia M, Incorvaia L, et al. Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway. Vol. 7, Oncotarget. 2016.

Satta T, Li L, Chalasani SL, Hu X, Nkwocha J, Sharma K, et al. Dual mTORC1/2 Inhibition Synergistically Enhances AML Cell Death in Combination with the BCL2 Antagonist Venetoclax. Clinical Cancer Research. 2023;29(7).

Escamilla-Ramírez A, Castillo-Rodríguez RA, Zavala-Vega S, Jimenez-Farfan D, Anaya-Rubio I, Briseño E, et al. Autophagy as a potential therapy for malignant glioma. Vol. 13, Pharmaceuticals. 2020.

Maycotte P, Aryal S, Cummings CT, Thorburn J, Morgan MJ, Thorburn A. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy. 2012;8(2).

Karasic TB, O’Hara MH, Loaiza-Bonilla A, Reiss KA, Teitelbaum UR, Borazanci E, et al. Effect of Gemcitabine and nab-Paclitaxel with or Without Hydroxychloroquine on Patients with Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2019;5(7).

Golden EB, Cho HY, Jahanian A, Hofman FM, Louie SG, Schönthal AH, et al. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Neurosurg Focus. 2014;37(6).

Cao C, Subhawong T, Albert JM, Kim KW, Geng L, Sekhar KR, et al. Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells. Cancer Res. 2006;66(20).

Imrali A, Mao X, Yeste-Velasco M, Shamash J, Lu Y. Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatin. Am J Cancer Res. 2016;6(8).

Wong SW, Tiong KH, Kong WY, Yue YC, Chua CH, Lim JY, et al. Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73. Breast Cancer Res Treat. 2011;128(2).

Zhou M, Luo C, Zhou Z, Li L, Huang Y. Improving anti-PD-L1 therapy in triple negative breast cancer by polymer-enhanced immunogenic cell death and CXCR4 blockade. Journal of Controlled Release. 2021;334.

Alissafi T, Hatzioannou A, Mintzas K, Barouni RM, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. Journal of Clinical Investigation. 2018;128(9).

Gewirtz DA. The challenge of developing autophagy inhibition as a therapeutic strategy. Cancer Res. 2016;76(19).

Troumpoukis D, Papadimitropoulou A, Charalampous C, Kogionou P, Palamaris K, Sarantis P, et al. Targeting autophagy in pancreatic cancer: The cancer stem cell perspective. Vol. 12, Frontiers in Oncology. 2022.

Zhou N, Liu Q, Wang X, He L, Zhang T, Zhou H, et al. The combination of hydroxychloroquine and 2-deoxyglucose enhances apoptosis in breast cancer cells by blocking protective autophagy and sustaining endoplasmic reticulum stress. Cell Death Discov. 2022;8(1).

Zhao W, Chen C, Zhou J, Chen X, Cai K, Shen M, et al. Inhibition of Autophagy Promotes the Anti-Tumor Effect of Metformin in Oral Squamous Cell Carcinoma. Cancers (Basel). 2022;14(17).

Fang J, Rhyasen G, Bolanos L, Rasch C, Varney M, Wunderlich M, et al. Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA 1. Blood. 2012;120(4).

Song H, Zhao Z, Ma L, Zhao W, Hu Y, Song Y. Novel exosomal circEGFR facilitates triple negative breast cancer autophagy via promoting TFEB nuclear trafficking and modulating miR-224-5p/ATG13/ULK1 feedback loop. Oncogene. 2024;43(11).

Schläfli AM, Adams O, Galván JA, Gugger M, Savic S, Bubendorf L, et al. Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer. Oncotarget. 2016;7(26).

Fu W, Wu G. Targeting mTOR for Anti-Aging and Anti-Cancer Therapy. Vol. 28, Molecules. 2023.

Theodorakis N, Feretzakis G, Tzelves L, Paxinou E, Hitas C, Vamvakou G, et al. Integrating Machine Learning with Multi-Omics Technologies in Geroscience: Towards Personalized Medicine. J Pers Med. 2024 Aug 31;14(9):931.

Sun F, Zhang L, Tong Z. Application progress of artificial intelligence in tumor diagnosis and treatment. Front Artif Intell. 2025 Jan 7;7.

Chude CI, Amaravadi RK. Targeting autophagy in cancer: Update on clinical trials and novel inhibitors. Vol. 18, International Journal of Molecular Sciences. 2017.




DOI: http://dx.doi.org/10.21622/AMPDR.2025.05.1.1251

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Samer Osama Kostandy, Salwa Aburageh Abuiessa, Mai Mostafa Helmy, Maged Wasfy Helmy

Advances in Medical, Pharmaceutical and Dental Research
E-ISSN: 2812-4898
P-ISSN: 2812-488X 

Published by:

Academy Publishing Center (APC)
Arab Academy for Science, Technology and Maritime Transport (AASTMT)
Alexandria, Egypt
ampdr@aast.edu